Maravai (NASDAQ: MRVI) General Counsel sells 50,000 shares under 10b5-1 plan
Rhea-AI Filing Summary
MARAVAI LIFESCIENCES HOLDINGS, INC. General Counsel Kurt Oreshack reported open-market sales of Class A Common Stock. He sold 25,000 shares on June 9, 2026 at $5.06 per share and 25,000 shares on June 10, 2026 at $5.10 per share. These transactions were effected under a pre-arranged Rule 10b5-1 trading plan. Following the sales, he directly holds 335,767 shares of Maravai Lifesciences stock.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Net Seller: 50,000 shares
Net Sell
2 txns
Insider
ORESHACK KURT
Role
General Counsel
Sold
50,000 shs ($254K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Class A Common Stock | 25,000 | $5.10 | $127K |
| Sale | Class A Common Stock | 25,000 | $5.06 | $126K |
Holdings After Transaction:
Class A Common Stock — 335,767 shares (Direct)
Footnotes (1)
- F1. The reported sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 10, 2026.
Key Figures
Shares sold June 9, 2026: 25,000 shares at $5.06
Shares sold June 10, 2026: 25,000 shares at $5.10
Total shares sold: 50,000 shares
+2 more
5 metrics
Shares sold June 9, 2026
25,000 shares at $5.06
Open-market sale of Class A Common Stock
Shares sold June 10, 2026
25,000 shares at $5.10
Open-market sale of Class A Common Stock
Total shares sold
50,000 shares
Two open-market sales reported in Form 4
Shares held after transactions
335,767 shares
Direct ownership after June 10, 2026 sale
Rule 10b5-1 plan adoption date
March 10, 2026
Plan governing reported sales
Key Terms
Rule 10b5-1 trading plan, Class A Common Stock, open-market sale, Form 4
4 terms
Rule 10b5-1 trading plan regulatory
"The reported sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 10, 2026."
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
Class A Common Stock financial
"The transactions involve non-derivative Class A Common Stock in open-market sales."
Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.
open-market sale financial
"Each transaction is described as an open-market sale of Class A Common Stock."
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
Form 4 regulatory
"The insider activity is reported in a Form 4 filing for Maravai Lifesciences."
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transaction did MRVI General Counsel Kurt Oreshack report?
Kurt Oreshack reported selling a total of 50,000 shares of Maravai Lifesciences Class A Common Stock in open-market transactions, split evenly over two days at prices slightly above $5.00 per share.
Were the MRVI insider stock sales made under a Rule 10b5-1 plan?
Yes. The filing states the reported sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 10, 2026, indicating the trades were pre-arranged.
What is the role of the insider selling MRVI stock in this Form 4?
The reporting person, Kurt Oreshack, is identified as an officer of Maravai Lifesciences with the title General Counsel. The transactions involve his directly owned Class A Common Stock holdings.
What type of transaction is reported in the MRVI Form 4 filing?
The Form 4 lists two open-market sales of non-derivative Class A Common Stock, coded as “S” for sale, with both transactions described as sales in open market or private transactions.